Arginine Alpha-Ketoglutarate

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: muscle energy heart

Research Overview

Across the abstracts provided, arginine alpha-ketoglutarate (AAKG) has been studied most often in the context of exercise performance—either as a standalone acute supplement (typically ~3–3.7 g taken pre-exercise) or as one component of multi-ingredient pre-workout supplements that also include stimulants and other ergogenic compounds (e.g., caffeine, beta-alanine, creatine nitrate). These studies have primarily assessed resistance-exercise outcomes (1RM strength, repetitions-to-failure/volume, chin-up/push-up endurance), limited anaerobic sprint measures, and acute physiological safety markers (heart rate, blood pressure, ECG, and clinical blood panels). A smaller but notable line of research in the provided set examines AAKG as part of a broader metabolic therapy (the “Deanna Protocol”) and/or combined with ketogenic feeding in an ALS mouse model, focusing on neurological function and survival.

The strongest evidence in these abstracts does not support an acute ergogenic benefit of AAKG alone for strength or muscular endurance. Two controlled acute studies found no improvement in bench press/leg press 1RM or total load volume versus placebo, and no improvement in upper-body endurance tasks; one study even reported small decrements in some repetition outcomes with AAKG. For multi-ingredient pre-workout products that include AAKG, the evidence suggests they are generally well-tolerated in young healthy adults under study conditions and may increase resting energy expenditure and improve subjective readiness/vigor and some cognitive measures, but they show limited or no consistent improvements in measured lifting volume or sprint performance; importantly, these effects cannot be attributed specifically to AAKG because of confounding by other active ingredients (notably caffeine and creatine-related compounds). In disease-related research, the ALS mouse study provides preclinical evidence that metabolic interventions including AAKG (as part of a multi-ingredient protocol) can modestly improve neurological scores and extend survival, but this remains animal data and does not isolate AAKG’s independent contribution.

Key gaps include a need for well-powered human trials that isolate AAKG (dose–response, timing, and chronic supplementation) and measure mechanistic endpoints relevant to its proposed nitric-oxide/vascular and metabolic roles (e.g., blood flow, endothelial function, muscle oxygenation, exercise metabolism), alongside standardized performance outcomes. For pre-workout formulations, factorial designs are needed to disentangle AAKG’s effects from stimulants and other ergogenic ingredients. Safety research also needs strengthening: while controlled trials reported no clinically meaningful acute changes in cardiovascular or laboratory markers, a case report of hemorrhagic stroke occurred after ingestion of a complex supplement containing multiple stimulatory compounds, underscoring the importance of ingredient-specific risk assessment, surveillance, and evaluation in higher-risk populations and real-world dosing patterns. Finally, translation of the ALS mouse findings requires rigorous clinical studies in humans, with designs capable of determining whether AAKG contributes independently to any therapeutic effect.

1. What conditions has Arginine Alpha-Ketoglutarate been studied for?

  • Exercise performance and training outcomes (strength, muscular endurance, sprint/anaerobic capacity, running performance, “readiness to perform,” cognition) in both trained and untrained people.

  • Safety/tolerability in healthy adults when included in multi-ingredient pre-workout supplements (including cardiovascular measures and clinical blood panels).

  • Amyotrophic lateral sclerosis (ALS) in an animal model (SOD1-G93A mice), as part of a metabolic therapy (“Deanna Protocol” ingredients) and/or combined with a ketogenic diet.

  • Blood pressure response to anaerobic exercise (acute AAKG vs placebo in trained men).

  • Muscle damage and power performance in adolescent runners when co-supplemented with HMB (β-hydroxy-β-methylbutyrate) plus AAKG.

  • Adverse event contexts reported in case reports involving multi-ingredient bodybuilding/pre-workout products that included AAKG (e.g., hemorrhagic stroke with Jack3d; drug-induced autoimmune hepatitis/cirrhosis after a muscle-building supplement containing AAKG among other ingredients).

2. Does it work in treating those conditions? Summarize the evidence.

  • Resistance exercise strength/endurance (AAKG alone, acute): Two placebo-controlled acute studies in men found no ergogenic benefit for 1RM strength or total lifting volume/repetitions to failure.

    • In resistance-trained and untrained men, 3,000 mg AAKG 45 minutes pre-exercise did not improve bench press or leg press 1RM or total load volume vs placebo.

    • In trained college-aged men given 3,700 mg per serving twice (4 hours and 30 minutes pre-exercise), AAKG did not improve local muscular endurance and participants actually performed fewer total chin-ups and fewer total repetitions in the supplement condition (statistically significant in the abstract).

  • Exercise performance when AAKG is part of a multi-ingredient pre-workout: Evidence is mixed and hard to attribute specifically to AAKG because the products also contained ingredients like caffeine, beta-alanine, creatine nitrate, tyrosine, etc.

    • Acute pre-workout study (mixed-sex, recreationally active): A pre-workout containing AAKG 2 g (plus caffeine and other ingredients) was well-tolerated and increased resting energy expenditure (REE) and improved some perceptions/cognitive scores, but showed no significant improvements in bench press volume, leg press volume, or sprint performance vs placebo.

    • 4–8 week training study (resistance-trained males): A similar pre-workout (with/without synephrine) showed some evidence of improved cognitive function and 1RM strength at 4 and/or 8 weeks compared with placebo, but effects were not clearly superior by 8 weeks and synephrine did not add benefit. Because AAKG was only one component, causality for AAKG cannot be established.

    • MIPS vs caffeine alone: A multi-ingredient pre-workout containing AAKG (and other ingredients) was less ergogenic than caffeine alone for bench press repetition volume, suggesting the blend (including AAKG) did not outperform caffeine by itself in that protocol.

  • ALS (animal model): In SOD1-G93A ALS mice, a metabolic therapy containing AAKG as the “main ingredient” (along with GABA, CoQ10, and MCT) showed improved neurological scores over a time window and extended survival when added to standard diet or ketogenic diet (reported survival extension of 7.5% and 4.2%, respectively). This is promising but preclinical; it does not establish efficacy in humans with ALS.

  • Jump performance in adolescent runners (AAKG + HMB): Over 12 days, co-supplementation with HMB (7.5 g) + AAKG (10 g) “might help” prevent decline in jump performance, but there was no influence on muscle damage markers or mood. Because AAKG was combined with HMB, the independent effect of AAKG is unclear.

3. What health benefits does it have?

  • Potential metabolic/neurologic benefit in ALS models (preclinical): In an ALS mouse model, AAKG-centered metabolic therapy (with other ingredients) improved neurological scoring and modestly extended survival. This suggests a possible role in targeting impaired energy metabolism in ALS, but human benefit is unproven.

  • Possible acute effects on perceived readiness/energy and cognition when included in pre-workouts: In an acute study of a pre-workout containing AAKG (2 g) plus other stimulatory/ergogenic ingredients, participants reported higher optimism/vigor/energy and showed greater improvements in some cognitive function scores vs placebo. However, these effects cannot be attributed specifically to AAKG (caffeine is a major confounder).

  • Safety signal in healthy users in controlled settings: In the acute pre-workout study, there were no clinically significant differences in heart rate, blood pressure, ECG, or general clinical blood panels among treatments, suggesting short-term tolerability of the multi-ingredient product in young healthy adults (again, this is not AAKG-only evidence).

  • Exercise performance benefits from AAKG alone are not supported in these abstracts: The AAKG-only acute trials did not show improvements in strength or endurance.

4. Does it have any downsides or side effects?

  • No performance benefit in multiple acute trials; possible performance decrement: In one trained-men endurance protocol, AAKG did not improve endurance and was associated with fewer total chin-ups and fewer total repetitions vs placebo (statistically significant), raising the possibility that it may hinder performance in some contexts.

  • Adverse events reported with multi-ingredient supplements that included AAKG (causality unclear):

    • Hemorrhagic stroke case report: A 26-year-old male developed a right thalamic hemorrhagic stroke after taking Jack3d, which contained AAKG among several other stimulants/compounds (including geranamine and caffeine). The report notes other ingredients may predispose to stroke/hemorrhage and highlights limited data for some constituents; it does not isolate AAKG as the cause.

    • Severe liver injury / drug-induced autoimmune hepatitis phenotype progressing to cirrhosis: A 48-year-old male developed severe hepatocellular injury after a muscle-building supplement containing AAKG along with L-citrulline, L-tyrosine, creatine malate, and beet extract. He had relapse after steroid withdrawal and later evidence of cirrhosis. This is a serious signal, but it is a single case report with multiple ingredients, so attribution to AAKG specifically is not possible from the abstract.

  • Short-term tolerability in controlled pre-workout trials: In the acute and 4–8 week pre-workout studies (AAKG included as one ingredient), there were no major differences vs placebo in clinical safety labs, blood pressure, or reported side effects in apparently healthy participants. This supports tolerability of those specific formulations under study conditions, but does not rule out rare idiosyncratic reactions.

  • Key limitation: Many safety concerns arise from multi-ingredient products; the abstracts provided do not establish the dose-specific risk profile of AAKG alone for rare events (e.g., liver injury).

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

  • No pharmacogenomic findings are reported in the provided abstracts. None of the studies stratified outcomes by genotype or evaluated gene–supplement interactions for AAKG.

  • ALS mouse model is genetic (SOD1-G93A), but this is not human pharmacogenomics: The ALS study used a transgenic SOD1-G93A model and found benefit from metabolic therapy containing AAKG. This suggests a potential interaction with a specific disease model driven by a mutation, but it does not demonstrate that particular human genetic variants predict benefit or harm from AAKG supplementation.

  • Clinical implication: Based on these abstracts alone, there is insufficient evidence to recommend AAKG specifically for (or against) people with any particular genetic variant.

References

  1. Effects of acute ingestion of a pre-workout dietary supplement with and without
    Y Peter Jung, Conrad P Earnest, Majid Koozehchian, Elfego Galvan, Ryan Dalton, Dillon Walker, Christopher Rasmussen, Peter S Murano, Mike Greenwood, Richard B Kreider (2017) - Journal of the International Society of Sports Nutrition
  2. Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.
    Csilla Ari, Angela M Poff, Heather E Held, Carol S Landon, Craig R Goldhagen, Nicholas Mavromates, Dominic P D'Agostino (2014) - PloS one
  3. Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males.
    Y Peter Jung, Conrad P Earnest, Majid Koozehchian, Minye Cho, Nick Barringer, Dillon Walker, Christopher Rasmussen, Mike Greenwood, Peter S Murano, Richard B Kreider (2017) - Journal of the International Society of Sports Nutrition
  4. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d.
    Colin Young, Olamide Oladipo, Samuel Frasier, Robert Putko, Stacy Chronister, Mary Marovich (2012) - Military medicine
  5. Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men.
    Benjamin Wax, Andreas N Kavazis, Heather E Webb, Stanley P Brown (2012) - Journal of the International Society of Sports Nutrition
  6. Acute arginine supplementation fails to improve muscle endurance or affect blood pressure responses to resistance training.
    Beau K Greer, Brett T Jones (2011) - Journal of strength and conditioning research
  7. Acute Effects of a Multi-Ingredient Pre-Workout Supplement On 5-KM Running Performance in Recreationally-Trained Athletes.
    Daniel J Lutsch, Clayton L Camic, Andrew R Jagim, Nora J Johnston, Taylor L Musgjerd (2019) - International journal of exercise science
  8. Effects of Multi-Ingredient Pre-Workout Supplement and Caffeine on Bench Press Performance: A Single-Blind Cross-Over Study.
    Marek Kruszewski, Maciej Merchelski, Artur Kruszewski, Rafał Tabęcki, Maksim Olegovich Aksenov, Łukasz Pągowski (2022) - Nutrients
  9. Effects of Co-Ingestion of β-Hydroxy-β-Methylbutyrate and L-Arginine α-Ketoglutarate on Jump Performance in Young Track and Field Athletes.
    Piotr Kaczka, Katarzyna Kubicka, Amit Batra, Marcin Maciejczyk, Edyta Kopera, Justyna Bira, Tomasz Zając (2021) - Nutrients
  10. A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis-Can We Draw a Line?
    Dorotea Božić, Ante Tonkić, Katarina Vukojevic, Maja Radman (2023) - Clinics and practice


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!